Mortality-associated plasma proteome dynamics in a prospective multicentre sepsis cohortResearch in context
Lars Palmowski,
Maike Weber,
Malte Bayer,
Yuxin Mi,
Karin Schork,
Martin Eisenacher,
Hartmuth Nowak,
Tim Rahmel,
Lars Bergmann,
Andrea Witowski,
Björn Koos,
Katharina Rump,
Dominik Ziehe,
Ulrich Limper,
Dietrich Henzler,
Stefan Felix Ehrentraut,
Alexander Zarbock,
Roman Fischer,
Julian C. Knight,
Michael Adamzik,
Barbara Sitek,
Thilo Bracht
Affiliations
Lars Palmowski
Klinik für Anästhesiologie, Intensivmedizin und Schmerztherapie, Universitätsklinikum Knappschaftskrankenhaus Bochum, Bochum, Germany
Maike Weber
Medizinisches Proteom-Center, Medical Faculty, Ruhr University Bochum, Bochum, Germany; Center for Protein Diagnostics (PRODI), Medical Proteome Analysis, Ruhr University Bochum, Bochum, Germany; CUBiMed.RUB, Core Unit Bioinformatics, Medical Faculty, Ruhr University Bochum, Bochum, Germany
Malte Bayer
Klinik für Anästhesiologie, Intensivmedizin und Schmerztherapie, Universitätsklinikum Knappschaftskrankenhaus Bochum, Bochum, Germany; Medizinisches Proteom-Center, Medical Faculty, Ruhr University Bochum, Bochum, Germany
Yuxin Mi
Center for Artificial Intelligence, Medical Informatics and Data Science, University Hospital Knappschaftskrankenhaus Bochum, Bochum, Germany
Karin Schork
Medizinisches Proteom-Center, Medical Faculty, Ruhr University Bochum, Bochum, Germany; Center for Protein Diagnostics (PRODI), Medical Proteome Analysis, Ruhr University Bochum, Bochum, Germany; CUBiMed.RUB, Core Unit Bioinformatics, Medical Faculty, Ruhr University Bochum, Bochum, Germany
Martin Eisenacher
Medizinisches Proteom-Center, Medical Faculty, Ruhr University Bochum, Bochum, Germany; Center for Protein Diagnostics (PRODI), Medical Proteome Analysis, Ruhr University Bochum, Bochum, Germany; CUBiMed.RUB, Core Unit Bioinformatics, Medical Faculty, Ruhr University Bochum, Bochum, Germany
Hartmuth Nowak
Klinik für Anästhesiologie, Intensivmedizin und Schmerztherapie, Universitätsklinikum Knappschaftskrankenhaus Bochum, Bochum, Germany; Daxing Research Institute, University of Science and Technology Beijing, Beijing, China
Tim Rahmel
Klinik für Anästhesiologie, Intensivmedizin und Schmerztherapie, Universitätsklinikum Knappschaftskrankenhaus Bochum, Bochum, Germany
Lars Bergmann
Klinik für Anästhesiologie, Intensivmedizin und Schmerztherapie, Universitätsklinikum Knappschaftskrankenhaus Bochum, Bochum, Germany
Andrea Witowski
Klinik für Anästhesiologie, Intensivmedizin und Schmerztherapie, Universitätsklinikum Knappschaftskrankenhaus Bochum, Bochum, Germany
Björn Koos
Klinik für Anästhesiologie, Intensivmedizin und Schmerztherapie, Universitätsklinikum Knappschaftskrankenhaus Bochum, Bochum, Germany
Katharina Rump
Klinik für Anästhesiologie, Intensivmedizin und Schmerztherapie, Universitätsklinikum Knappschaftskrankenhaus Bochum, Bochum, Germany
Dominik Ziehe
Klinik für Anästhesiologie, Intensivmedizin und Schmerztherapie, Universitätsklinikum Knappschaftskrankenhaus Bochum, Bochum, Germany
Ulrich Limper
Department of Anesthesiology and Operative Intensive Care Medicine, University of Witten/Herdecke, Cologne Merheim Medical School, Cologne 51109, Germany
Dietrich Henzler
Department of Anesthesiology, Surgical Intensive Care, Emergency and Pain Medicine, Ruhr-University Bochum, Klinikum Herford, Herford 32049, Germany
Stefan Felix Ehrentraut
Klinik für Anästhesiologie und Operative Intensivmedizin, Universitätsklinikum Bonn, Bonn 53127, Germany
Alexander Zarbock
Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital of Münster, Münster, Germany
Roman Fischer
Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, UK; Chinese Academy of Medical Science Oxford Institute, University of Oxford, Oxford OX3 7BN, UK
Julian C. Knight
Chinese Academy of Medical Science Oxford Institute, University of Oxford, Oxford OX3 7BN, UK; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK; NIHR Oxford Biomedical Research Centre, Oxford OX3 9DU, UK
Michael Adamzik
Klinik für Anästhesiologie, Intensivmedizin und Schmerztherapie, Universitätsklinikum Knappschaftskrankenhaus Bochum, Bochum, Germany
Barbara Sitek
Klinik für Anästhesiologie, Intensivmedizin und Schmerztherapie, Universitätsklinikum Knappschaftskrankenhaus Bochum, Bochum, Germany; Medizinisches Proteom-Center, Medical Faculty, Ruhr University Bochum, Bochum, Germany
Thilo Bracht
Klinik für Anästhesiologie, Intensivmedizin und Schmerztherapie, Universitätsklinikum Knappschaftskrankenhaus Bochum, Bochum, Germany; Medizinisches Proteom-Center, Medical Faculty, Ruhr University Bochum, Bochum, Germany; Corresponding author. Klinik für Anästhesiologie, Intensivmedizin und Schmerztherapie, Universitätsklinikum Knappschaftskrankenhaus Bochum, In der Schornau 23-25, Bochum D-44892, Germany.
Summary: Background: Sepsis remains a leading cause of mortality in intensive care units. Understanding the dynamics of the plasma proteome of patients with sepsis is critical for improving prognostic and therapeutic strategies. Methods: This prospective, multicentre observational cohort study included 363 patients with sepsis recruited from five university hospitals in Germany between March 2018 and April 2023. Plasma samples were collected on days 1 and 4 after sepsis diagnosis, and proteome analysis was performed using mass spectrometry. Classical statistical methods and machine learning (random forest) were employed to identify proteins associated with 30-day survival outcomes. Findings: Out of 363 patients, 224 (62%) survived, and 139 (38%) did not survive the 30-day period. Proteomic analysis revealed significant differences in 87 proteins on day 1 and 95 proteins on day 4 between survivors and non-survivors. Additionally, 63 proteins were differentially regulated between day 1 and day 4 in the two groups. The identified protein networks were primarily related to blood coagulation, immune response, and complement activation. The random forest classifier achieved an area under the receiver operating characteristic curve of 0.75 for predicting 30-day survival. The results were compared and partially validated with an external sepsis cohort. Interpretation: This study describes temporal changes in the plasma proteome associated with mortality in sepsis. These findings offer new insights into sepsis pathophysiology, emphasizing the innate immune system as an underexplored network, and may inform the development of targeted therapeutic strategies. Funding: European Regional Development Fund of the European Union. The State of North Rhine-Westphalia, Germany.